Dana Investment Advisors, Inc. Rocket Pharmaceuticals, Inc. Transaction History
Dana Investment Advisors, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Dana Investment Advisors, Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 17,608 shares of RCKT stock, worth $197,913. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,608
Previous 14,981
17.54%
Holding current value
$197,913
Previous $276,000
19.93%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding RCKT
# of Institutions
213Shares Held
93.1MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$199 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$126 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$69.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$62.2 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$50.5 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $851M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...